Tag: HER2-positive breast cancer treatment

In the relentless battle against HER2-positive breast cancer, a groundbreaking breakthrough is emerging from the cutting-edge intersection of radiopharmaceuticals and ...

In a groundbreaking study published in BMC Health Services Research, researchers Lochid-amnuay and Kongsakon delve into the cost-utility and budget ...

A groundbreaking development in the treatment of HER2-positive breast cancer has emerged, heralding a new era in radioimmunotherapy that promises ...

In a groundbreaking advancement for oncology, a recent study has shed new light on treatment strategies for older patients with ...

In a groundbreaking development presented at the ESMO Congress 2025, the oncology field witnesses a transformative leap forward with the ...

In the rapidly evolving realm of oncology, understanding the mechanisms that confer drug resistance remains one of the most formidable ...

Metformin, a drug primarily prescribed to manage type 2 diabetes, has increasingly captured the attention of oncologists and cancer researchers ...

In the relentless battle against HER2-positive breast cancer, trastuzumab (commonly known by its brand name, Herceptin) has long stood as ...

The landscape of HER2-positive breast cancer treatment continues to evolve rapidly, with researchers tirelessly seeking enhanced neoadjuvant therapies that can ...

In a groundbreaking pooled analysis combining data from the TRYPHAENA and NeoSphere trials, researchers have brought new insights into the ...